Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2010
05/05/2010CN1736456B Extracts of composite Chinese medicinal plants for treating diabetic gastrointestinal disease and preparation thereof
05/05/2010CN1733133B Antifatigue health food capsule
05/05/2010CN1724044B Compound medicinal preparation for treating colitis
05/05/2010CN1679912B Extraction of liuwei Dihuang polysaccharide, products and use thereof
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
05/05/2010CN101701032A Quinoxalinone low molecular weight peptide derivative with matrix metalloproteinases inhibition function and preparation method and application thereof
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/05/2010CN101700392A Traditional Chinese medicine composite for curing obesity fatty liver
05/05/2010CN101700390A Oral traditional Chinese medicine composition for treating fatty liver
05/05/2010CN101700386A Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof
05/05/2010CN101700381A Pill for healing hepatitis B and softening liver
05/05/2010CN101700378A Method for preparing cyperus-amomum stomach soft capsule
05/05/2010CN101700377A Medicinal liquor for treating gastroenteropathy and preparation method thereof
05/05/2010CN101700376A Traditional Chinese medicine for treating virus B hepatitis
05/05/2010CN101700371A Traditional Chinese medicine for treating bacillary dysentery
05/05/2010CN101700366A Tincture for treating toothache
05/05/2010CN101700361A Dendrobium candidum instant powder and preparation method thereof
05/05/2010CN101700359A Medicine for treating gastrosis
05/05/2010CN101700358A Medicine for treating acute and chronic nonspecific ulcerative colitis and preparation method thereof
05/05/2010CN101700357A Traditional Chinese medicine for treating gastric ulcer
05/05/2010CN101700349A Liquid hard capsule of Anagex extract and preparation method thereof
05/05/2010CN101700344A Traditional Chinese medicine preparation for treating hypopyretic toothache
05/05/2010CN101700342A Pharmaceutical composition for treating hepatitis B and preparation method thereof
05/05/2010CN101700341A Biological composition for nourishing kidney and protecting liver and preparation method for oral liquid thereof
05/05/2010CN101700337A Oral traditional Chinese medicine composition for treating chronic gastritis
05/05/2010CN101700335A Traditional Chinese medicinal preparation for treating chronic appendicitis
05/05/2010CN101700319A Traditional Chinese medicine for preventing and treating loach and finless eel enteritis
05/05/2010CN101700311A Method for producing lozenge capable of tonifying qi and soothing nerves
05/05/2010CN101700300A Traditional Chinese medicine volatile oil composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS), and preparation method and applications thereof in preparation of medicaments
05/05/2010CN101700299A Traditional Chinese medicine preparation for curing oral ulcer
05/05/2010CN101700296A Chinese herbal preparation for curing gastroenteritis and preparation method thereof
05/05/2010CN101700289A Traditional Chinese medicine extract composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS), and preparation method and applications thereof in preparation of medicaments
05/05/2010CN101700287A Traditional Chinese medicine composition for treating gastropathy and preparation method and quality control method thereof
05/05/2010CN101700285A Application of rumex japonicus in preparing medicines
05/05/2010CN101700283A Drug for curing chronic hepatitis B
05/05/2010CN101700278A Composition for treating liver injury
05/05/2010CN101700268A Liver protection soft capsules
05/05/2010CN101700263A Method for preparing acer truncatum buge oil microemulsion
05/05/2010CN101700262A Quality control method of andrographis paniculata dropping pills
05/05/2010CN101700260A Purslane seed polysaccharide granule preparation and preparation method thereof
05/05/2010CN101700253A Probiotic tablet and preparation method thereof
05/05/2010CN101700239A Combined capsule filled with glycyrrhizin solid preparation and glycine solid preparation
05/05/2010CN101700231A Solid preparation comprising pantoprazole sodium submicron emulsion particles
05/05/2010CN101700227A Matrine colon targeted adhesive pellet and preparation method thereof
05/05/2010CN101700220A Tooth brushing powder for cleaning teeth and removing ozostomia
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709500 Chemical compounds
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
05/04/2010US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist
05/04/2010US7709451 Method and composition for treating immune complex associated disorders
05/04/2010US7709449 Treating hepatitis infections, particularly hepatitis B viral infections; modified oligonucleotides
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010US7708988 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium
05/04/2010US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents
05/04/2010CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators
05/04/2010CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2427385C Nutritional composition for an immune condition
05/04/2010CA2347981C Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby
05/04/2010CA2172398C Methods and products for controlling immune responses in mammals
04/2010
04/29/2010WO2010048573A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
04/29/2010WO2010047928A2 Methods and compositions for treatment of fibrosis
04/29/2010WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010046321A1 Nutritional composition with anti-regurgitation properties
04/29/2010WO2010009091A3 Anti-inflammatory and anti-allergy extracts from nettle
04/29/2010US20100105953 Human Adam-10 Inhibitors
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
04/29/2010US20100105867 Process for producing osteocalcin-containing extract
04/29/2010US20100105777 Amide or thioamide derivatives and their use in the treatment of pain
04/29/2010US20100105757 Treatment and inhibition of disease conditions using flexible heteroarotinoids
04/29/2010US20100105727 Novel benzamide derivatives and process for the prepartion thereof
04/29/2010US20100105715 Polymer conjugates of opioid antagonists
04/29/2010US20100105701 Gyrase inhibitors and uses thereof
04/29/2010US20100105693 Modulators of Muscarinic Receptors
04/29/2010US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers
04/29/2010US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
04/29/2010US20100105679 5-pyridinone substituted indazoles
04/29/2010US20100105651 Antagonists of sns sodium channels
04/29/2010US20100105639 Mesalamine suppository
04/29/2010US20100105603 Methods and Preparations For Curing Clinically Ill Patients
04/29/2010US20100104637 Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
04/29/2010US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome
04/29/2010US20100104581 Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions
04/29/2010US20100104564 Altered Antibody Fc Regions and Uses Thereof
04/29/2010US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
04/29/2010US20100104545 Nutritional Composition To Promote Healthy Development And Growth
04/29/2010US20100104532 Nucleoside analogs for antiviral treatment
04/29/2010US20100104527 Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties